XJPX
4918
Market cap11mUSD
Oct 09, Last price
325.00JPY
1D
9.43%
1Q
-3.85%
Jan 2017
-92.35%
Name
Ivy Cosmetics Corp
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Ivy Cosmetics Corporation manufactures and distributes a comprehensive array of cosmetic products and beauty-enhancing supplements. Their extensive catalog includes fundamental skincare items like deep-penetrating beauty liquids, various lotions, emulsions, creams, and cleansing or face wash solutions. Additionally, the company provides specialized care treatments, makeup, hair care, and body care products, along with health foods and equipment, UV protection items, and a line of men's cosmetics. Established in 1975, the enterprise was initially known as Shirogane Corporation, adopting its current name, Ivy Cosmetics Corporation, in October 1977. The company's headquarters are located in Tokyo, Japan.
Key people
Kazunori Egawa
Manager of Corporate Planning, Director · since 2025
Seijin Nakayama
Director of Business Administration, Director · since 2022
Keishi Nakayama
Director · since 2022
Yu Nomoto
Director · since 2022
Emiko Shirogane
Chairman of the Board · since 1996
Koji Shirogane
President, Representative Director · since 2001
Kazuko Shirogane
Director · since 2021
Masakazu Tajima
Managing Director, Director of Product Planning · since 2022
Independent Director · since 2022
Tsukasa Wada
Independent Director · since 2022
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑03 | 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||